🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will investigate the efficacy and tolerability of a short (6 mon...
Status
Unknown
Location
Medical University Innsbruck
Start Date
2004-01
Trial ID
NCT00327262
Treatments Being Tested
Following the ACOSOG Z9001trial, imatinib received market authorization in ...
Status
Unknown
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT02576080
Treatments Being Tested
The primary objective of this trial is to improve the overall survival rate...
Status
Recruiting
Location
Subang Jaya Medical Centre
Start Date
2020-03-04
Trial ID
NCT06336395
Phase I/II trial to study the effectiveness of combining STI571 and chemoth...
Status
Completed
Location
University of California at Los Angeles (UCLA )
Start Date
2001-05
Trial ID
NCT00015834
Treatments Being Tested
The purpose of this study is to compare the relapse free survival and overa...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2012-08
Trial ID
NCT01782508
Treatments Being Tested
ALLTogether collects the experience of previously successful treatment of i...
Status
Recruiting
Location
L'hôpital Universitaire des enfants Reine Fabiola (Huderf)
Start Date
2020-07-13
Trial ID
NCT04307576
Primary objective To determine maximum tolerated dose \& dose limiting toxi...
Status
Completed
Location
Duke University Health System
Start Date
2005-05
Trial ID
NCT00613132
Treatments Being Tested
The purpose of this study is to determine the safety and effectiveness of a...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2007-04
Trial ID
NCT00476190
Any time the words "you," "your," "I," or "me" appear, it is meant to apply...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2013-03-05
Trial ID
NCT01319981
Imatinib (IM) has dramatically improved survival of gastrointestinal stroma...
Status
Terminated
Location
University of Utah
Start Date
2007-07
Trial ID
NCT00585221
Treatments Being Tested